News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
10-Jan-2007 - The Translational Medicine Research Collaboration (TMRC) announced the first round of research projects to be funded through the new £50 million initiative. Almost £8 million of funding has been released to support 28 new research projects covering a wide range of therapeutic areas including ...
07-Nov-2006 - Ablynx, has announced that they have entered into an exclusive research collaboration and license agreement with Wyeth Pharmaceuticals, a division of Wyeth, to discover, develop and commercialise Nanobodies® directed at the tumour necrosis factor alpha (TNF-) protein and its receptors that target ...
26-Oct-2006 - Affymetrix Inc. announced that Wyeth has signed another agreement with Affymetrix to use GeneChip(R) microarray technology for three more years, further extending the relationship that began in 1994. Under the agreement, Wyeth will continue to apply Affymetrix technology in numerous areas of the ...
14-Sep-2006 - Intercell AG announced that it has closed a worldwide nonexclusive agreement under which Wyeth has the right to use Intercell's fully synthetic novel adjuvant IC31TM in various selected infectious disease vaccine programs. Under the agreement, Intercell may be entitled to receive up to USD 77 ...
09-Aug-2006 - Karo Bio announced that Wyeth and Karo Bio extended their atherosclerosis collaboration for an additional year until August 31, 2007. The primary objective of the extension is to characterize back up compounds and to further evaluate additional clinical possibilities by targeting LXR. The ...
28-Jun-2006 - NovaScreen Biosciences Corporation, a Caliper Life Sciences Company, announced that Wyeth Pharmaceuticals, a division of Wyeth, has selected NovaScreen to conduct a high-throughput screening (HTS) campaign. As a result, NovaScreen will screen 500,000 compounds against an inflammatory target. The ...
20-Apr-2006 - ArQule, Inc. announced the receipt of a milestone payment from Wyeth in connection with the filing of an Investigational New Drug (IND) application by Wyeth to the U.S. Food and Drug Administration (FDA) related to a compound under development for Alzheimer's disease. Under its previously ...
29-Dec-2005 - Wyeth Pharmaceuticals, a division of Wyeth and Progenics Pharmaceuticals, Inc. announced that they have entered into an exclusive, worldwide agreement for the joint development and commercialization of methylnaltrexone (MNTX) for the treatment of opioid-induced side effects, including ...
12-Sep-2005 - XOMA Ltd. announced that it has granted Wyeth a non-exclusive, worldwide license for XOMA's expression technology. Under the agreement, Wyeth receives a license to use XOMA's technology for the development and production of recombinant proteins. Details of the initial payment and future ...
Ireland Plant centerpiece of Wyeth's growing investment in biotech processes and products
09-Sep-2005 - Wyeth formally opened its Grange Castle biotech production facility in South County Dublin, Ireland. The new 1.2 million square foot campus is one of the largest integrated biotech manufacturing facilities in the world and is expected to produce some of the Company's most innovative ...
© 1997-2024 LUMITOS AG, All rights reserved